Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Start with a complimentary consultation, no obligation Our medical provider will evaluate your health history and determine if B12/MIC injections are right for you
GSH protects the cells from ROS by reducing the ROS forms and is converted to its oxidised form GSSH
spending on GLP-1s soared: total annual spending reached nearly $72 billion in 2023 ( [20] ) and climbed to approximately $52.7 billion in US market revenue in 2025 (accounting for 75.3% of the global GLP-1 market), with projections pointing toward $155.9 billion by 2033 ( [21] )
Semaglutide or Tirzepatide cannot be prescribed to anyone with the following and should not be purchased: BMI under 27, eating disorder, gallbladder disease, drug or alcohol abuse, recent bariatric surgery, pancreatitis, medullary thyroid cancer, currently pregnant or breastfeeding, planning to become pregnant, Diabetic retinopathy, Multiple endocrine neoplasia type 2, or a family history of medullary thyroid carcinoma
Where legitimacy stops: your genetic baseline Even a fully credentialed program does not see the biology it is prescribing into
In the SURMOUNT-1 study, which established the standard escalation protocol, gastrointestinal side effects occurred primarily during dose escalation periods, not during maintenance phases
US$ 23.52
US$ 21.68
US$ 21.60
US$ 24.81
US$ 21.76
US$ 21.99
